CLINICAL_TRIALS
trial_result
· 2021-09-27
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia [Phase 3]
Summary
Phase 3 trial update evaluating tocilizumab for COVID-19 pneumonia in hospitalized patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: COVID-19 Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2021-09-27